参考文献/References:
[1]肝衰竭诊治指南(2018年版)[J].临床肝胆病杂志,2019,35(1):38-44.
[2]贺凡.血清甲胎蛋白及NLR在165例慢加急性肝衰竭患者的临床转归分析[D].重庆医科大学,2018.
[3]崔春吉.血清CA199检测在肝硬化中的临床价值[J].临床消化病杂志,2016,28(2):79-80.
[4]花艳艳,许琳婧,李剧.甲胎蛋白检测在肝病患者中的临床意义[J].中国现代药物应用,2018,12(13):72-73.
[5]徐少卿,郭建彪,李红艳,等.血清甲胎蛋白与慢加急性肝衰竭预后的关系[J].临床消化病杂志,2014,26(1):46-47.
[6]李雷,林芳,孙李建,等.ROC曲线评价AFP在急性肝衰竭预后中的应用[J].中华临床医师杂志(电子版),2013,7(2):559-561.
[7]赵萍.AFP和PTA水平对ACLF患者预后的预测价值研究[D].新乡医学院,2017.
[8]安晓刚,张旭,马玉,等.血清甲胎蛋白对HBV相关慢加急性肝衰竭患者的预后分析[J].宁夏医学杂志,2017,39(10):900-901.
[9]赵萍,翟玉峰,张怀宏.血清甲胎蛋白和凝血酶原活动度水平对慢加急性肝衰竭患者预后的预测价值研究[J].实用肝脏病杂志,2017,20(2):230-231.
[10]张磐,杨爽,周彧来.血清甲胎蛋白水平对乙肝相关慢加急性肝衰竭患者短期预后的评判作用分析[J].实用预防医学,2017,24(7):875-878.
[11]熊会玲,范彦,胡美,等.血清CA199对良恶性胆道疾病的意义[J].临床消化病杂志,2013,25(6):327-329.
[12]汪洁.慢性乙型肝炎、乙型重型肝炎、乙肝肝硬化患者血清CA125、CA199、CEA、SF的改变及其意义[D].华中科技大学,2016.
[13]邱正强.血清CEA、AFP、CA199、CA125在肝炎及肝硬化患者中的检测意义[J].湖南师范大学学报(医学版),2017,14(3):171-174.
相似文献/References:
[1]张秀灵,牟春燕,李 武.非生物人工肝支持系统的临床应用现状及进展[J].医学信息,2018,31(02):40.[doi:10.3969/j.issn.1006-1959.2018.02.014]
ZHANG Xiu-ling,MOU Chun-yan,LI Wu.Current Status and Progress of Clinical Application of Abiotic Artificial Liver Support System[J].Journal of Medical Information,2018,31(09):40.[doi:10.3969/j.issn.1006-1959.2018.02.014]
[2]李映节,孔宪炳.部分肝切除术后肝功能衰竭的影响因素及术前评估研究[J].医学信息,2019,32(03):37.[doi:10.3969/j.issn.1006-1959.2019.03.013]
LI Ying-jie,KONG Xian-bing.Influential Factors and Preoperative Evaluation of Liver Failure after Partial Hepatectomy[J].Journal of Medical Information,2019,32(09):37.[doi:10.3969/j.issn.1006-1959.2019.03.013]
[3]胡思芹,李运新,曾福英.血清AFP、CEA、CA199、CA724联合检测对消化道恶性肿瘤的诊断价值[J].医学信息,2020,33(15):170.[doi:10.3969/j.issn.1006-1959.2020.15.054]
HU Si-qin,LI Yun-xin,ZENG Fu-ying.The Diagnostic Value of Combined Detection of Serum AFP,CEA,CA199,CA724 for Malignant Tumors of Digestive Tract[J].Journal of Medical Information,2020,33(09):170.[doi:10.3969/j.issn.1006-1959.2020.15.054]
[4]张杏羡.化学发光免疫法对肿瘤生物标志物的检验效果分析[J].医学信息,2022,35(20):154.[doi:10.3969/j.issn.1006-1959.2022.20.043]
ZHANG Xing-xian.Analysis of the Effect of Chemiluminescence Immunoassay on Tumor Biomarkers[J].Journal of Medical Information,2022,35(09):154.[doi:10.3969/j.issn.1006-1959.2022.20.043]
[5]吴春城,张满英,梁惠卿,等.论凉血散血法在肝衰竭治疗中的应用[J].医学信息,2020,33(19):160.[doi:10.3969/j.issn.1006-1959.2020.19.051]
[6]郭 婷,王伟新,张丽丽.血浆置换联合分子吸附再循环系统治疗肝衰竭的疗效[J].医学信息,2020,33(24):104.[doi:10.3969/j.issn.1006-1959.2020.24.028]
GUO Ting,WANG Wei-xin,ZHANG Li-li.The Effect of Plasma Exchange Combined with Molecular Adsorption Recirculation System in the Treatment of Liver Failure[J].Journal of Medical Information,2020,33(09):104.[doi:10.3969/j.issn.1006-1959.2020.24.028]
[7]闫红林,杨永勤,汪 雯,等.老年肝衰竭临床特点及预后转归[J].医学信息,2021,34(05):65.[doi:10.3969/j.issn.1006-1959.2021.05.019]
YAN Hong-lin,YANG Yong-qin,WANG Wen,et al.Clinical Characteristics and Prognostic Outcome of Elderly Liver Failure[J].Journal of Medical Information,2021,34(09):65.[doi:10.3969/j.issn.1006-1959.2021.05.019]
[8]宁 萍,王雪婷,李奋荣,等.基于EP9-A3文件对两仪器测定血清甲胎蛋白、癌胚抗原结果的可比性评价[J].医学信息,2024,37(05):138.[doi:10.3969/j.issn.1006-1959.2024.05.025]
NING Ping,WANG Xue-ting,LI Fen-rong,et al.Comparability of the Results of Serum Alpha-fetoprotein and Carcinoembryonic Antigen Measured by the Two Instruments Based on the EP9-A3 Document[J].Journal of Medical Information,2024,37(09):138.[doi:10.3969/j.issn.1006-1959.2024.05.025]
[9]杨 璨,田江红,李俊燕,等.血清AFP、GP73及PIVKA-Ⅱ检测对原发性肝癌的诊断效能[J].医学信息,2024,37(06):125.[doi:10.3969/j.issn.1006-1959.2024.06.021]
YANG Can,TIAN Jiang-hong,LI Jun-yan,et al.Diagnostic Efficacy of Serum AFP, GP73 and PIVKA-Ⅱ in Primary Liver Cancer[J].Journal of Medical Information,2024,37(09):125.[doi:10.3969/j.issn.1006-1959.2024.06.021]